Company / FCF Margin
Editas Medicine, Inc. FCF Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-678.1%
FY2025
5-year range
-920.6% / -206.1%
FY2021-FY2025
Trend
+26.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2025 after 2 years of decline, reaching -678.1%.
Based on SEC 10-K filings.
-678.1% in FY2025 with a 5-year CAGR of -520.1%.
Remained stable around -678.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -472.0pp
- 5-Year Change
- -520.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 26.3% year-over-year.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -678.1% | +26.3% |
| FY2024 | -920.6% | -36.9% |
| FY2023 | -672.5% | -226.3% |
| FY2022 | -206.1% | +9.6% |
| FY2021 | -228.1% | -44.4% |
| FY2020 | -158.0% | -89.0% |
| FY2019 | -83.6% | +90.6% |
| FY2018 | -887.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026